Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Form 8.3 - [NCC GROUP PLC - Opening Disclosure - 17 07 2025] - (CGAML)
-
Canaccord Genuity Reiterates Buy Rating on Exact Sciences (EXAS)
-
Canaccord Genuity Reiterates Buy Rating on Fractyl Health Inc (GUTS)
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $105 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Netflix (NFLX)
-
Heartflow (HTFL) Files for Proposed IPO
-
NTG Clarity Announces Closing of Its Brokered LIFE Offering
-
Form 8.3 - [MARLOWE PLC - 16 07 2025] - (CGWL)
-
Wedbush Securities Welcomes Daniel Shea as Managing Director of Consumer & Diversified Industries Investment Banking
-
Wedbush Securities Welcomes Daniel Shea as Managing Director of Consumer & Diversified Industries Investment Banking
-
SharkNinja (SN) PT Raised to $136 at Canaccord Genuity
-
CoTec Holdings Corp. Announces Third and Final Closing of Upsized Life Offering, Total Raise to Date of $12.4 Million
-
Sierra Madre Announces Upsize of Best Efforts Private Placement of Units to $16.5 Million
-
Meta Platforms Inc. (META) PT Raised to $850 at Canaccord Genuity
-
MP Materials (MP) PT Raised to $64 at Canaccord Genuity
-
AngioDynamics (ANGO) PT Raised to $17 at Canaccord Genuity
-
Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference
-
Form 8.3 - [MARLOWE PLC - 15 07 2025] - (CGWL)
-
Canaccord Genuity Upgrades Jupiter Fund Management (JUP:LN) to Hold
-
Canaccord Genuity Starts EML Payments Ltd (EML:AU) (EMCHF) at Buy
-
Canaccord Genuity Reiterates Buy Rating on Redwire (RDW)
-
Canaccord Genuity Reiterates Buy Rating on Hillman Solutions Corp. (HLMN)
-
TransMedics Group (TMDX) PT Raised to $142 at Canaccord Genuity
-
Form 8.3 - [MARLOWE PLC - 14 07 2025] - (CGWL)
-
Operational Update
-
Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025
-
VIZSLA SILVER ANNOUNCES CLOSING OF OVER-ALLOTMENT OPTION IN FULL
-
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
-
Tylenol maker Kenvue ousts CEO amid board's strategic review
-
Canaccord Genuity Reiterates Buy Rating on Central Garden & Pet Co. (CENT)
-
Vertical Aerospace Ltd. (EVTL) PT Lowered to $11 at Canaccord Genuity
-
Form 8.3 - [ALPHA GROUP INTERNATIONAL PLC - 11 07 2025] - (CGAML)
-
Thor Explorations Announces Q2 2025 Operating Update
-
MP Materials (MP) PT Raised to $55 at Canaccord Genuity
-
Form 8.3 - [ALPHA GROUP INTERNATIONAL PLC - 10 07 2025] - (CGAML)
-
Canaccord Genuity Downgrades North American Construction Group (NOA:CN) (NOA) to Hold
-
Form 8.3 - [MARLOWE PLC - 09 07 2025] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Exact Sciences (EXAS)
-
Canaccord Genuity Reiterates Buy Rating on GH Research PLC (GHRS)
-
Canaccord Genuity Reiterates Buy Rating on Ultragenyx Pharma (RARE)
-
EZCORP (EZPW) PT Raised to $25 at Canaccord Genuity
-
Rhythm Pharmaceuticals prices $175 million stock offering at $85 per share
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
-
Total Voting Rights
-
Rhythm Pharmaceuticals announces $150 million stock offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
-
GK Resources and Syntholene Energy Announce Brokered Private Placement of up to C$4.0 Million
-
SGHC Limited (SGHC) PT Raised to $15 at Canaccord Genuity
-
Canaccord Genuity Reiterates Hold Rating on Edwards Lifesciences (EW)
-
Canaccord Genuity Starts Redwire (RDW) at Buy

